Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FEMYNASDAQ:LLITNASDAQ:MDAINASDAQ:NMTC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEMYFemasys$1.16+1.8%$1.30$0.86▼$1.80$31.60M-2.52236,652 shs90,302 shsLLITLianluo Smart$3.67-2.4%$9.91$2.76▼$17.14$8.11M0.161.04 million shs42,316 shsMDAISpectral AI$1.18+1.7%$1.33$0.82▼$3.25$29.87M0.59840,839 shs102,525 shsNMTCNeuroOne Medical Technologies$0.61-6.5%$0.74$0.40▼$1.39$28.91M0.65176,851 shs477,926 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEMYFemasys+2.38%-0.85%+3.57%-1.69%-16.55%LLITLianluo Smart-2.39%-0.81%-30.29%+723.24%+325.16%MDAISpectral AI+1.72%-8.53%-0.84%-42.72%-31.79%NMTCNeuroOne Medical Technologies-6.51%-1.28%+38.66%-42.98%-46.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFEMYFemasys2.6118 of 5 stars3.55.00.00.00.02.50.6LLITLianluo SmartN/AN/AN/AN/AN/AN/AN/AN/AMDAISpectral AI2.7662 of 5 stars3.74.00.00.01.53.30.0NMTCNeuroOne Medical Technologies2.1122 of 5 stars3.53.00.00.02.31.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFEMYFemasys 3.00Buy$11.50891.38% UpsideLLITLianluo Smart 0.00N/AN/AN/AMDAISpectral AI 3.33Buy$4.75302.54% UpsideNMTCNeuroOne Medical Technologies 3.00Buy$1.45137.67% UpsideCurrent Analyst Ratings BreakdownLatest LLIT, NMTC, FEMY, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.454/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/28/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.003/19/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$12.00 ➝ $15.003/18/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/13/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.00 ➝ $12.002/26/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.00 ➝ $12.002/11/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.00 ➝ $12.00(Data available from 5/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFEMYFemasys$1.63M19.40N/AN/A$0.85 per share1.36LLITLianluo Smart$380K21.35N/AN/A($0.59) per share-6.22MDAISpectral AI$29.58M1.01N/AN/A($0.10) per share-11.80NMTCNeuroOne Medical Technologies$5.75M5.03N/AN/A$0.10 per share6.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFEMYFemasys-$14.25M-$0.85N/AN/AN/A-1,435.77%-141.49%-82.30%N/ALLITLianluo Smart-$4.45MN/A0.00∞N/AN/AN/AN/AN/AMDAISpectral AI-$20.85M-$0.84N/AN/AN/A-40.78%N/A-77.87%N/ANMTCNeuroOne Medical Technologies-$12.32M-$0.26N/A∞N/A-82.17%-270.70%-129.70%5/13/2025 (Estimated)Latest LLIT, NMTC, FEMY, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025FEMYFemasys-$0.17-$0.23-$0.06-$0.23N/AN/A3/27/2025Q4 2024FEMYFemasys-$0.25-$0.23+$0.02-$0.23$1.66 million$0.58 million3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 million2/12/2025Q1 2025NMTCNeuroOne Medical TechnologiesN/A$0.06N/A$0.06N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFEMYFemasysN/AN/AN/AN/AN/ALLITLianluo SmartN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFEMYFemasys0.863.943.26LLITLianluo SmartN/A2.422.17MDAISpectral AIN/A0.730.69NMTCNeuroOne Medical TechnologiesN/A3.642.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFEMYFemasys65.27%LLITLianluo Smart28.75%MDAISpectral AI67.08%NMTCNeuroOne Medical Technologies16.07%Insider OwnershipCompanyInsider OwnershipFEMYFemasys12.32%LLITLianluo Smart22.90%MDAISpectral AI56.73%NMTCNeuroOne Medical Technologies8.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFEMYFemasys3027.24 million20.08 millionNot OptionableLLITLianluo Smart62.21 millionN/ANot OptionableMDAISpectral AI8325.32 million8.04 millionNot OptionableNMTCNeuroOne Medical Technologies2047.39 million28.12 millionOptionableLLIT, NMTC, FEMY, and MDAI HeadlinesRecent News About These CompaniesLadenburg Thalmann Initiates Coverage of NeuroOne Medical Technologies (NMTC) with Buy RecommendationMay 6 at 3:27 AM | msn.comNeuroOne Medical Technologies (NASDAQ:NMTC) Now Covered by Analysts at LADENBURG THALM/SH SHMay 6 at 2:33 AM | americanbankingnews.comNeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global ConferenceMay 5, 2025 | newsfilecorp.comNeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern TimeMay 1, 2025 | globenewswire.comNeuroOne completes FDA submission for nerve ablation tech to treat facial painApril 24, 2025 | massdevice.comNeuroOne Medical completes FDA submission for OneRF Ablation System RFApril 24, 2025 | markets.businessinsider.comNeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial PainApril 23, 2025 | globenewswire.comNeuroOne Medical Technologies Corporation: NeuroOne Issues Letter to ShareholdersApril 17, 2025 | finanznachrichten.deNeuroOne says tariffs won’t impact business, Zimmer Biomet dealApril 17, 2025 | massdevice.comNeuroOne® Issues Letter to ShareholdersApril 16, 2025 | globenewswire.comNeuroOne Medical’s OneRF technology featured in Fox News storyApril 15, 2025 | markets.businessinsider.comNeuroOne® OneRF® Technology Success Story Featured on Fox NewsApril 14, 2025 | globenewswire.comRonald McClurg Spends US$100k On NeuroOne Medical Technologies StockApril 10, 2025 | finance.yahoo.comDavid A. Rosa Purchases 100,000 Shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) StockApril 9, 2025 | insidertrades.comNasdaq Dips 5%; NeuroOne Medical Technologies Shares PlummetApril 4, 2025 | benzinga.comNeuroOne prices $8M offeringApril 4, 2025 | massdevice.comNeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common StockApril 4, 2025 | globenewswire.comNeuroOne Medical announces common stock offering, no amount givenApril 4, 2025 | markets.businessinsider.comNeuroOne announces public offering of sharesApril 3, 2025 | msn.comNeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common StockApril 3, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatAST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockBy Jea Yu | April 21, 2025View AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockLLIT, NMTC, FEMY, and MDAI Company DescriptionsFemasys NASDAQ:FEMY$1.16 +0.02 (+1.75%) Closing price 05/8/2025 03:57 PM EasternExtended Trading$1.11 -0.05 (-4.31%) As of 05/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Lianluo Smart NASDAQ:LLITLianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.Spectral AI NASDAQ:MDAI$1.18 +0.02 (+1.72%) Closing price 05/8/2025 04:00 PM EasternExtended Trading$1.19 +0.01 (+1.19%) As of 05/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.NeuroOne Medical Technologies NASDAQ:NMTC$0.61 -0.04 (-6.51%) Closing price 05/8/2025 03:57 PM EasternExtended Trading$0.64 +0.03 (+5.06%) As of 05/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Energy Transfer Undervalued or a Value Trap? Carvana’s Stock Price Rebound Shifts Into a Higher Gear Why Investors Should Be Careful About AMC's Bitcoin Dreams Alphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone? Joby's Q1: Key Milestones Achieved as Path to Market Crystalizes Rockwell Automation: Tailwinds From Onshoring U.S. Production IBM's AI Offensive: Assessing IBM's Path to Renewed Growth Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
